• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 18 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 18 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Model Number 1013470-150
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/30/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that this was a procedure to treat a long lesion in the superficial femoral artery (sfa) with heavy calcification.An antegrade access was used in the right common femoral vein.A command guide wire successfully crossed the target lesion.Then a 6.0x150mm armada 18 balloon dilatation catheter (bdc) was advanced to the target lesion without issue; however, the balloon ruptured at 10 atmospheres during the first inflation.Therefore, the balloon was removed and the procedure continued with a 6.0x120 mm armada 18 bdc.The new armada was advanced to the target lesion without issue; however, the balloon ruptured at 4 atmospheres during the first inflation.The balloon was removed and a decision was made to laser the lesion.Then another armada bdc was successfully used to dilate the lesion.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device has returned for evaluation.The investigation has not yet been completed.A follow-up report will be submitted with all additional relevant information.The additional vascular device referenced are filed under separate medwatch report number.
 
Additional Manufacturer Narrative
Visual inspection was performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation determined the reported balloon rupture appears to be related to operational context.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Event or Problem Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 18 PTA CATHETER
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13043324
Report Number2024168-2021-11864
Device Sequence Number17483881
Product Code LIT
UDI-Device Identifier08717648208447
UDI-Public08717648208447
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
K151317
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2024
Device Model Number1013470-150
Device Catalogue Number1013470-150
Device Lot Number1061041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2021
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/30/2021
Supplement Date Received by Manufacturer01/08/2022
Initial Report FDA Received Date12/20/2021
Supplement Report FDA Received Date01/19/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/10/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
COMMAND GUIDEWIRE
Patient Age71 YR
Patient SexFemale
Patient Weight88 KG
-
-